Armata Pharmaceuticals, Inc. (ARMP) Misses Q1 EPS by 52c

Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q1 EPS of ($0.69), $0.52 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $970 thousand versus the consensus estimate of $1 million.

For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• On Holding AG (ONON) Stock: Market Doesn't Appreciate Brand's Potential, Says Analyst
• UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order